Medical/Pharmaceuticals
NICHIBAN to Establish European Subsidiary "NICHIBAN EUROPE GmbH" in Germany
TOKYO, July 21, 2020 /PRNewswire/ -- NICHIBAN CO., LTD., based in Tokyo, announced that it will open a new European subsidiary, "NICHIBANEUROPE GmbH" in Dusseldorf, Germany, in October 2020. As part of the expansion of the company's overseas business, NICHIBAN opened a representative office inDu...
Samsung Biologics Expands Drug Product Manufacturing Facility in Incheon
SONGDO, South Korea, July 20, 2020 /PRNewswire/ -- Samsung Biologics
(207940.KS) announced a plan to expand its Drug Product (DP) capability in line
with increasing market demand and to ensure flexible production capabilities
for new and existing clients.
D-Link Launches Group Temperature Screening Camera Kit with AI Facial Recognition
TAIPEI, July 20, 2020 /PRNewswire/ -- D-Link today announced the new DCS-9500T
Group Temperature Screening Camera Kit
D-Link Launches Group Temperature Screening Camera Kit with AI Facial Recognition
TAIPEI, July 21, 2020 /PRNewswire/ -- D-Link today announced the new DCS-9500T
Group Temperature Screening Camera Kit
China NMPA Accepts NDA Submission of Ripretinib for Advanced Gastrointestinal Stromal Tumor
SHANGHAI and SAN FRANCISCO and WALTHAM, Mass., July 20, 2020 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB) and Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that the China National Medical Products Administration (NMPA) has accepted its New Drug Application (NDA) for ripretinib...
JW Therapeutics Acquires Syracuse Biopharma and Its in-Licenses With Eureka Therapeutics' Solid Tumor Technologies in China
SHANGHAI and EMERYVILLE, Calif., July 20, 2020 /PRNewswire/ -- JW Therapeutics
PHASE Scientific Announces CE Mark Approval for the PHASIFY(TM) VIRAL RNA Extraction Kit
GARDEN GROVE, Calif., July 20, 2020 /PRNewswire/ -- PHASE Scientific, a fast-growing biotechnology company, announces today it has received the Conformité Européene (CE) Mark approval for its PHASIFY™ VIRAL RNA Extraction Kit. The CE marking confirms that PHASIFY™ VIRAL complies with the European...
Connect Biopharma Initiates Phase 2 Clinical Trial of CBP-201 in Adult Patients with Moderate-to-Severe Atopic Dermatitis
SAN DIEGO and TAICANG, SUZHOU, China, July 20, 2020 /PRNewswire/ -- Connect Biopharma, a clinical-stage biopharmaceutical company focused on identifying and developing potent and specific immune modulating molecules, today announced that the first patient has been dosed in a Phase 2 clinical tria...
New Medical Findings From 10-year Study of 3D Printed Regenerative Implant Osteoplug
SINGAPORE, July 20, 2020 /PRNewswire/ -- Osteopore International Pte Ltd, a global leader in regenerative implants, today revealed new data that demonstrates the long-term safety and efficacy of Osteoplug, a 3D printed bioresorbable polycaprolactone (PCL) bone graft implant, that enables the reg...
Docquity partners with global pharma leader to support the continuing education of medical professionals across 7 countries in Asia
SINGAPORE, July 20, 2020 /PRNewswire/ -- Docquity, Southeast Asia's largest professional network of doctors, has partnered with Swiss research-based healthcare company Novartis to deliver bite-sized, continual learning, and education support to doctors across seven countries inAsia. Novartis will...
Meta-Analysis from Biosense Webster, Inc. Reveals Positive Effects of Real-Time Ultrasound Imaging During Cardiac Ablation to Treat Arrhythmias
TOKYO, July 20, 2020 /PRNewswire/ -- Biosense Webster, Inc., part of the Johnson & Johnson Medical Devices Companies*, in collaboration with researchers at the Tokyo Medical and Dental University and CTI Clinical Trial Consulting published findings in the Journal of Cardiovascular Electrophysiol...
World Brain Day 2020 "Moves to End Parkinson's Disease"
On July 22, World Brain Day is dedicated to raising awareness to improve the lives of those with Parkinson's Disease and their caregivers LONDON, July 20, 2020 /PRNewswire/ -- On July 22, the World Federation of Neurology (WFN) is partnering with the International Parkinson and Movement Disorder...
PHASE Scientific Announces CE Mark Approval for the PHASIFY(TM) VIRAL RNA Extraction Kit
HONG KONG, July 20, 2020 /PRNewswire/ -- PHASE Scientific, a fast-growing biotechnology company, announces today it has received the Conformité Européene (CE) Mark approval for its PHASIFY™ VIRAL RNA Extraction Kit. The CE marking confirms that PHASIFY™ VIRAL complies with the European In-Vitro D...
Bridging Study in China Completed for NASH Drug Candidate ASC40
HANGZHOU and SHAOXING, China, July 20, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today that a single-dose, pharmacokinetic bridging study of non-alcoholic steatohepatitis (NASH) drug candidate ASC40 (TVB-2640) in 34 Chinese subjects has been completed and data indicate...
Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization
SHANGHAI, July 20, 2020 /PRNewswire/ -- Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed...
Esaote "Takes to the Track" Alongside Ducati Team for MotoGP 2020's First Grand Prix Back
Sunday 19 July, Jerez de la Frontera (Spain) Esaote and Ducati Corse confirm their partnership, which is centred around innovation in performance and Italian style GENOA, Italy, July 17, 2020 /PRNewswire/ -- The first MotoGP 2020 Grand Prix after the long pause triggered by the global COVID-19 c...
PerfectPrime Unleashes World's First Handheld Thermal Camera For Fever Detection With Top Accuracy
HONG KONG, July 17, 2020 /PRNewswire/ -- The world is facing a never before seen crisis which has cost economies billions of dollars and affected an unprecedented number of lives. The coronavirus has forced people to stay home and out of work at its peak but businesses are now slowly opening up a...
New Early Breast Cancer Drug Now Approved in Malaysia
SINGAPORE, July 16, 2020 /PRNewswire/ -- A NEW breast cancer drug shown to significantly reduce the risk of cancer recurrence is now approved for use in Malaysia. The drug, NERLYNX (neratinib), is an oral medication taken by women with breast cancer who have had surgery, chemotherapy and prior tr...
VectraCor and GS GmbH (Corpuls) Form Licensing Agreement to Incorporate VectraCor's 22-Lead ECG and CEB® (Cardiac Electrical Biomarker) Technology in Corpuls Defibrillators
Both Companies Committed to Bringing the Best Cardiac Care to the Healthcare Workers and Patients that Need It TOTOWA, New Jersey, July 17, 2020 /PRNewswire/ -- GS Elektromedizinische Geraete G. Stemple GmbH, marketing defibrillators under the corpuls brand, and VectraCor Inc., announced today t...
MindBeauty Launches Upgraded AA99 Reusable Face Mask that is Certified to Work Against Coronavirus
HONG KONG, July 16, 2020 /PRNewswire/ -- Since the launch of the original AA99® Reusable Face Mask in March 2020, MindBeauty has been working with consumers and technical experts to modify its mask in line with current global healthcare needs and is proud to announce, to the best oftheir knowledg...
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00